Efficacy chemotherapeutic drug screening assays antitumor. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy18

Cell Line, Tumor Tumor Cells, Cultured Cell Line KB Cells HCT116 Cells HT29 Cells Neoplastic Stem Cells HL-60 Cells K562 Cells Cells, Cultured Hep G2 Cells Mitochondria HeLa Cells MCF-7 Cells Spheroids, Cellular T-Lymphocytes, Cytotoxic CD8-Positive T-Lymphocytes Dendritic Cells

Organisms7

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL Adenoviridae Oncolytic Viruses Cricetinae

Diseases38

Neoplasms Neoplasms, Experimental Breast Neoplasms Melanoma, Experimental Lung Neoplasms Colonic Neoplasms Leukemia P388 Melanoma Ovarian Neoplasms Sarcoma 180 Adenocarcinoma Liver Neoplasms Leukemia L1210 Fibrosarcoma Prostatic Neoplasms Neuroblastoma Brain Neoplasms Carcinoma, Hepatocellular Pancreatic Neoplasms Disease Models, Animal Mammary Neoplasms, Experimental Neovascularization, Pathologic Osteosarcoma Neoplasm Metastasis Glioblastoma Glioma Carcinoma Lymphoma Bone Neoplasms Carcinoma, Lewis Lung Colorectal Neoplasms Leukemia Sarcoma, Experimental Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Multiple Myeloma Necrosis Skin Neoplasms

Chemicals and Drugs114

Antineoplastic Agents Doxorubicin Antibiotics, Antineoplastic Cisplatin Paclitaxel Antineoplastic Agents, Phytogenic Etoposide P-Glycoprotein Fluorouracil Antineoplastic Agents, Alkylating Antimetabolites, Antineoplastic Proto-Oncogene Proteins c-bcl-2 Camptothecin Tumor Suppressor Protein p53 Daunorubicin Caspases Deoxycytidine Vinblastine Vincristine RNA, Small Interfering Cyclophosphamide Mitomycin Drug Carriers Apoptosis Regulatory Proteins Caspase 3 TNF-Related Apoptosis-Inducing Ligand Antibodies, Monoclonal Enzyme Inhibitors Neoplasm Proteins Multidrug Resistance-Associated Proteins bcl-X Protein Taxoids Prodrugs Dacarbazine Methotrexate Bleomycin Mitoxantrone Organoplatinum Compounds Carmustine Angiogenesis Inhibitors Cancer Vaccines Receptors, TNF-Related Apoptosis-Inducing Ligand Teniposide bcl-2-Associated X Protein Pyrazines RNA, Messenger Inhibitor of Apoptosis Proteins ATP-Binding Cassette Transporters Fenretinide Protein Kinase Inhibitors Boronic Acids Melphalan Cytarabine Piperazines Nanoconjugates Proto-Oncogene Proteins c-akt Radiation-Sensitizing Agents Plant Extracts Antigens, CD95 Recombinant Proteins Topoisomerase II Inhibitors Proto-Oncogene Proteins Membrane Glycoproteins DNA, Neoplasm Organoselenium Compounds Bridged Compounds Dactinomycin Poly(ADP-ribose) Polymerases Carboplatin Chlorambucil Imidazoles Quinazolines Sulfonamides Caspase 8 Tumor Necrosis Factor-alpha Pyrimidines P-Glycoproteins Caspase 9 Rhodamine 123 Antigens, Neoplasm Protein-Serine-Threonine Kinases DNA-Binding Proteins DNA NF-kappa B Caspase 7 Flavonoids Fas Ligand Protein Polyethylene Glycols Myeloid Cell Leukemia Sequence 1 Protein Pyridines Enediynes Histone Deacetylase Inhibitors Indoles Drug Combinations Benzamides Ceramides Nuclear Proteins Receptor, Epidermal Growth Factor Cyclin-Dependent Kinase Inhibitor p21 Reactive Oxygen Species X-Linked Inhibitor of Apoptosis Protein TOR Serine-Threonine Kinases Glutathione Immunotoxins STAT3 Transcription Factor Tubulin Modulators Intracellular Signaling Peptides and Proteins Cytochromes c Recombinant Fusion Proteins Carrier Proteins Cell Cycle Proteins Antibodies, Monoclonal, Humanized Topoisomerase I Inhibitors Sirolimus

Analytical, Diagnostic and Therapeutic Techniques and Equipment39

Drug Screening Assays, Antitumor Xenograft Model Antitumor Assays Neoplasm Transplantation Antineoplastic Combined Chemotherapy Protocols Neoplasms, Experimental Drug Delivery Systems Inhibitory Concentration 50 Treatment Outcome Melanoma, Experimental Transplantation, Heterologous Blotting, Western Flow Cytometry Drug Carriers Immunotherapy Transfection Combined Modality Therapy Drug Evaluation, Preclinical Tumor Burden Drug Administration Schedule Genetic Therapy Disease Models, Animal Mammary Neoplasms, Experimental Electrochemotherapy Tumor Stem Cell Assay Reverse Transcriptase Polymerase Chain Reaction Nanoconjugates Models, Biological Clinical Trials as Topic Oncolytic Virotherapy Immunohistochemistry Drug Therapy, Combination Immunotherapy, Adoptive Injections, Intralesional Administration, Oral Sarcoma, Experimental Immunoblotting Gene Knockdown Techniques In Situ Nick-End Labeling Double-Blind Method

Phenomena and Processes42

Drug Resistance, Neoplasm Apoptosis Drug Synergism Cell Survival Drug Resistance, Multiple Dose-Response Relationship, Drug Cell Proliferation Inhibitory Concentration 50 Gene Expression Regulation, Neoplastic Cell Cycle Drug Resistance DNA Damage Time Factors Cell Division Signal Transduction Transfection Cell Death Down-Regulation Up-Regulation Enzyme Activation Cell Growth Processes RNA Interference Genetic Vectors Phosphorylation DNA Fragmentation Gene Expression DNA Repair Gene Silencing Tissue Distribution Genes, MDR Mutation Structure-Activity Relationship Protein Binding Molecular Structure Cytotoxicity, Immunologic Membrane Potential, Mitochondrial G2 Phase Kinetics Base Sequence Necrosis Autophagy Cell Movement

Disciplines and Occupations2

Nanomedicine Immunohistochemistry

Technology, Industry, Agriculture4

Nanomedicine Nanoparticles Nanoconjugates Polyethylene Glycols

Information Science2

Molecular Sequence Data Base Sequence

Health Care3

Treatment Outcome Clinical Trials as Topic Double-Blind Method

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Health Care

Antineoplastic Agents Cell Line, Tumor Doxorubicin Drug Screening Assays, Antitumor Drug Resistance, Neoplasm Antibiotics, Antineoplastic Apoptosis Xenograft Model Antitumor Assays Cisplatin Drug Synergism Tumor Cells, Cultured Neoplasms Mice, Nude Paclitaxel Cell Survival Antineoplastic Agents, Phytogenic Drug Resistance, Multiple Dose-Response Relationship, Drug Neoplasm Transplantation Etoposide P-Glycoprotein Cell Proliferation Fluorouracil Antineoplastic Agents, Alkylating Antineoplastic Combined Chemotherapy Protocols Neoplasms, Experimental Antimetabolites, Antineoplastic Drug Delivery Systems Mice, Inbred BALB C Inhibitory Concentration 50 Breast Neoplasms Proto-Oncogene Proteins c-bcl-2 Mice, SCID Camptothecin Treatment Outcome Gene Expression Regulation, Neoplastic Melanoma, Experimental Tumor Suppressor Protein p53 Cell Cycle Daunorubicin Lung Neoplasms Caspases Deoxycytidine Drug Resistance Colonic Neoplasms Vinblastine Transplantation, Heterologous DNA Damage Time Factors Leukemia P388 Vincristine RNA, Small Interfering Blotting, Western Cell Division Cyclophosphamide Flow Cytometry Mitomycin Drug Carriers Signal Transduction Mice, Inbred C57BL Apoptosis Regulatory Proteins Caspase 3 Immunotherapy Transfection Cell Death Combined Modality Therapy TNF-Related Apoptosis-Inducing Ligand Antibodies, Monoclonal Enzyme Inhibitors Melanoma Drug Evaluation, Preclinical Neoplasm Proteins Tumor Burden Multidrug Resistance-Associated Proteins bcl-X Protein Taxoids Prodrugs Ovarian Neoplasms Drug Administration Schedule Dacarbazine Sarcoma 180 Methotrexate Adenocarcinoma Bleomycin Mitoxantrone Genetic Therapy Liver Neoplasms Organoplatinum Compounds Leukemia L1210 Nanomedicine Carmustine Angiogenesis Inhibitors Cell Line Down-Regulation Cancer Vaccines Receptors, TNF-Related Apoptosis-Inducing Ligand Fibrosarcoma Teniposide KB Cells Prostatic Neoplasms

No FAQ available that match "efficacy chemotherapeutic drug screening assays antitumor"